Kiyoyuki Furuse
- Oncology top 0.5%
- Lung Cancer Research Studies 68
- Cancer Treatment and Pharmacology 30
- Neutropenia and Cancer Infections 17
- Colorectal Cancer Treatments and Studies 13
- Pulmonary and Respiratory Medicine top 0.2%
- Lung Cancer Treatments and Mutations 63
- Lung Cancer Diagnosis and Treatment 33
- Otorhinolaryngology top 1%
- Radiation top 1%
-
- Cancer therapeutics and mechanisms 36
-
- Neuroendocrine Tumor Research Advances 26
- Co-authors
- Masaaki KawaharaY AriyoshiMasahiro FukuokaNobuyuki KatagamiYoshiki TakadaH NishikawaShinzoh KudohKaoru Kubota
- Journals
- Journal of Clinical Oncology (18 papers)JNCI Journal of the National Cancer Institute (1 paper)Cancer (4 papers)
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Kiyoyuki Furuse
144 papers receiving 6.2k citations
Hit Papers
Peers
Comparison fields: 5 of 112
- Oncology 3.8k
- Pulmonary and Respiratory Medicine 4.3k
- Otorhinolaryngology 336
- Radiation 651
- Radiology, Nuclear Medicine and Imaging 655
Countries citing papers authored by Kiyoyuki Furuse
This map shows the geographic impact of Kiyoyuki Furuse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kiyoyuki Furuse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kiyoyuki Furuse more than expected).
Fields of papers citing papers by Kiyoyuki Furuse
This network shows the impact of papers produced by Kiyoyuki Furuse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kiyoyuki Furuse. The network helps show where Kiyoyuki Furuse may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kiyoyuki Furuse, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung Cancerbreakdown → | 2010 | 1329 |
| 2 | 2007 | 6 | |
| 3 | 2007 | 47 | |
| 4 | 1998 | 5 | |
| 5 | 1997 | 37 | |
| 6 | 1996 | 6 | |
| 7 | 1995 | 49 | |
| 8 | Phase I clinical study on new vinca alkaloid derivative, KW 2307 (vinorelbine) | 1994 | 2 |
| 9 | 1994 | 43 | |
| 10 | 1993 | 50 | |
| 11 | 1993 | 20 | |
| 12 | 1992 | 7 | |
| 13 | W-III-6 DOSE INTENSIVE WEEKLY CODE CHEMOTHERAPY (CT) WITH OR WITHOUT rhG-CSF IN EXTENSIVE-STAGE (ES) SMALL CELL LUNG CANCER (SCLC). | 1991 | 0 |
| 14 | 1991 | 37 | |
| 15 | Activation of the cytokine network by muroctasin as a remedy for leukopenia and thrombopenia. | 1989 | 10 |
| 16 | 1989 | 1 | |
| 17 | 1989 | 1 | |
| 18 | 1987 | 160 | |
| 19 | 1986 | 1 | |
| 20 | 1985 | 1 |
About Kiyoyuki Furuse
Kiyoyuki Furuse is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Microbiology, having authored 155 papers that have together received 6.4k indexed citations. Recurring topics across this work include Lung Cancer Research Studies (68 papers), Lung Cancer Treatments and Mutations (63 papers), Cancer therapeutics and mechanisms (36 papers), Lung Cancer Diagnosis and Treatment (33 papers), Cancer Treatment and Pharmacology (30 papers), Neuroendocrine Tumor Research Advances (26 papers), Neutropenia and Cancer Infections (17 papers) and Colorectal Cancer Treatments and Studies (13 papers). The work is most often cited by research in Oncology (3.8k citations), Pulmonary and Respiratory Medicine (4.3k citations) and Otorhinolaryngology (336 citations). Kiyoyuki Furuse has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Masaaki Kawahara, Y Ariyoshi, Masahiro Fukuoka, Nobuyuki Katagami, Yoshiki Takada, H Nishikawa, Shinzoh Kudoh, Kaoru Kubota, M. Fukuoka and P. Fournel. Their work appears in journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.